Is Zimmer Biomet Holdings, Inc. overvalued?

Zimmer Biomet Holdings, Inc. (ZBH) looks undervalued — trading about 106% below its fair value.

Undervalued

Price

$103.21

Fair value

$212.26

Current P/E

12.2

Normal P/E

25.0

Market cap

$19.53B

Dividend yield

0.9%

Return on equity

6.1%

Sector

Healthcare

Fair value compares ZBH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks